- Home
- DCTH vs OSUR Comparison
DCTH vs OSUR Comparison
Compare DCTH & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- OSUR
- Stock Information
- Founded
- DCTH 1988
- OSUR 2000
- Country
- DCTH United States
- OSUR United States
- Employees
- DCTH N/A
- OSUR 501
- Industry
- DCTH Medical/Dental Instruments
- OSUR Medical/Dental Instruments
- Sector
- DCTH Health Care
- OSUR Health Care
- Exchange
- DCTH Nasdaq
- OSUR Nasdaq
- Market Cap
- DCTH 426.3M
- OSUR 228.1M
- IPO Year
- DCTH N/A
- OSUR 1986
- Fundamental
- Price
- DCTH $11.86
- OSUR $3.08
- Analyst Decision
- DCTH Strong Buy
- OSUR Hold
- Analyst Count
- DCTH 4
- OSUR 1
- Target Price
- DCTH $24.00
- OSUR $3.00
- AVG Volume (30 Days)
- DCTH 873.0K
- OSUR 761.3K
- Earning Date
- DCTH 08-04-2025
- OSUR 08-05-2025
- Dividend Yield
- DCTH N/A
- OSUR N/A
- EPS Growth
- DCTH N/A
- OSUR N/A
- EPS
- DCTH N/A
- OSUR N/A
- Revenue
- DCTH $53,850,000.00
- OSUR $161,626,000.00
- Revenue This Year
- DCTH $155.42
- OSUR N/A
- Revenue Next Year
- DCTH $37.93
- OSUR $6.80
- P/E Ratio
- DCTH N/A
- OSUR N/A
- Revenue Growth
- DCTH 1068.87
- OSUR N/A
- 52 Week Low
- DCTH $7.17
- OSUR $2.36
- 52 Week High
- DCTH $18.23
- OSUR $4.92
- Technical
- Relative Strength Index (RSI)
- DCTH 32.83
- OSUR 63.30
- Support Level
- DCTH $12.11
- OSUR $3.00
- Resistance Level
- DCTH $14.15
- OSUR $3.13
- Average True Range (ATR)
- DCTH 0.57
- OSUR 0.12
- MACD
- DCTH -0.16
- OSUR 0.01
- Stochastic Oscillator
- DCTH 9.67
- OSUR 100.00
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.